Here’s a big ol’ shocker: Martin Shkreli’s Turing Pharmaceuticals is reportedly reneging on its pledge to reduce the price of Daraprim, the parasitic infection medication whose price they hiked to $750 per tablet back in August.Read more...
Chris Thompson, Gawker
Wed, 11/25/2015 - 5:24pm
Here’s a big ol’ shocker: Martin Shkreli’s Turing Pharmaceuticals is reportedly reneging on its pledge to reduce the price of Daraprim, the parasitic infection medication whose price they hiked to $750 per tablet back in August.Read more...